JSPR
Jasper Therapeutics Inc
0.6091$
+4.1%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | -152.6% | – | -147.6% | – | -100.0% | – | – | – | – | -100.0% | – | -100.0% | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | -31.5% | +18.3% | +15.1% | +14.4% | +2.5% | +1.6% | +1.1% | -26.8% | -70.3% | +251.2% | +3.8% | +80.9% | +8.5% | -52.5% | -7.5% | – | – | -92.8% | – | – | |
| – | – | – | – | – | -152.6% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -147.5% | – | – | – | – | – | – | |
| – | +146.2% | -5.4% | +2.8% | -4.9% | +16.7% | +39.4% | +20.4% | -5.4% | -0.6% | +10.9% | +2.9% | +5.6% | +35.6% | +11.7% | -6.8% | -25.6% | +9.7% | +28.0% | +36.8% | -18.3% | +31.2% | -32.1% | -21.1% | -48.8% | -11.7% | – | |
| – | +61.6% | +20.4% | -11.9% | +39.9% | +77.9% | -11.4% | +18.5% | +34.0% | -16.6% | -3.7% | +21.1% | -7.2% | +9.4% | -0.4% | -13.8% | +22.7% | -1.6% | +15.7% | +1.5% | +2.4% | +4.2% | -18.8% | -6.2% | +14.2% | -20.4% | – | |
| – | +122.3% | -0.1% | -0.8% | +5.0% | +34.6% | +19.7% | +19.9% | +5.8% | -6.4% | +6.2% | +8.2% | +1.5% | +27.8% | +8.6% | -8.5% | -16.6% | +8.2% | +24.4% | +27.1% | -13.8% | +24.2% | -29.2% | -17.4% | -31.0% | -15.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | +3,529.7% | -13.1% | +0.0% | -99.7% | +33,511.1% | +249.5% | -85.3% | -82.8% | +100.0% | -41.6% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -99.9% | +393,707.5% | -14.4% | +73.8% | -100.1% | – | – | – | – | – | – | – | -212.3% | – | – | -87.2% | -222.2% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -112.7% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.